Europe’s mRNA leadership strengthens amid US policy shocks

EU PERSPECTIVES - In July 2025, US health secretary Robert F. Kennedy Jr. scrapped $500 million in mRNA research contracts, citing vague safety fears and backing "whole-virus vaccines" instead. The move opens a rare opportunity to cement Europe's global leadership in mRNA, leveraging its strong industrial base, academic depth, and supportive policy evolution. Read more

The promise of mRNA extends far beyond COVID-19. Photo: Spencer Davis (Unsplash)